Boehringer Can Keep Many Docs On Barr Deal Away From FTC

Law360, New York (September 27, 2012, 8:41 PM EDT) -- A Washington federal judge ruled Thursday that many of the documents the Federal Trade Commission had sought from Boehringer Ingelheim Pharmaceuticals Inc. about its patent settlements with Barr Pharmaceuticals Inc. were privileged but ordered the drugmaker to quickly turn over the rest.

U.S. Magistrate Judge John M. Facciola found that Boehringer's financial analyses of a co-promotion agreement it reached with Barr for one of its drugs were an integral part of the patent litigation, requested by the company's attorneys to help evaluate settlement offers. This made...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

FEDERAL TRADE COMMISSION v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.


Case Number

1:09-mc-00564

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

G. Michael Harvey

Date Filed

October 23, 2009

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.